ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
0,00%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,525
-0,20%
Bitcoin
65 278,08
0,48%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. ResMed Inc (RMD)

  7. ResMed Inc (RMD) Actualités

RMD ResMed Inc

212,27
1,92 (0,91%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ResMed Inc RMD NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,92 0,91% 212,27 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
210,82 210,17 212,62 212,27 210,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/6/202415:05GLOBEPAP Therapy Reduces Hospitalizations by 31% and ER Visits by..
24/5/202418:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202415:05GLOBEDeveloped in Collaboration with Leading Scientists, New..
22/5/202420:51EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
16/5/202422:35GLOBEATS 2024: New ResMed-Supported Research Shows Increasing..
16/5/202414:05GLOBEMatrixCare Joins Health Gorilla’s Qualified Health..
15/5/202416:58EDGAR2Form 144 - Report of proposed sale of securities
07/5/202422:05GLOBEResMed Announces Participation in the RBCCM Global..
25/4/202422:05GLOBEResMed Inc. Announces Results for the Third Quarter of..
04/4/202422:05GLOBEResMed to Report Third Quarter Fiscal 2024 Earnings on April..
15/3/202408:05GLOBEResMed's 2024 Global Sleep Survey Uncovers a World in Sleep..
07/3/202402:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:05GLOBEIntroducing the AirFit F40: Experience Unprecedented Freedom..
05/3/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:55EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:08EDGAR2Form 144 - Report of proposed sale of securities
24/2/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202403:41EDGAR2Form 144 - Report of proposed sale of securities
12/2/202422:16GLOBEResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare..
07/2/202414:05GLOBEMatrixCare Earns Three 2024 Best in KLAS Awards
06/2/202417:21EDGAR2Form 144 - Report of proposed sale of securities
29/1/202412:09IHMARKETNEWSPhilips Shares Drop 6% as US Sales Halted Following..
25/1/202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202422:06EDGAR2Form 8-K - Current report
24/1/202422:05GLOBEResMed Inc. Announces Results for the Second Quarter of..
03/1/202422:05GLOBEResMed to Report Second Quarter Fiscal 2024 Earnings on..
03/1/202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:05GLOBEResMed Announces Participation in the 42nd Annual J.P...
20/12/202322:05GLOBEResMed Notifies Customers About Updated Instructions and..
11/12/202322:05GLOBEResMed Secures Significant Victory in Patent Fight Against..
07/12/202321:34GLOBEStudy Estimates a 23% Increase in COPD by 2050, Representing..
30/11/202301:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202323:26EDGAR2Form 144 - Report of proposed sale of securities
27/11/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:01EDGAR2Form 144 - Report of proposed sale of securities
22/11/202318:58EDGAR2Form 144 - Report of proposed sale of securities
21/11/202302:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202301:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202300:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202300:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:10EDGAR2Form 8-K - Current report
17/11/202303:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NYSE
RMD
ResMed
USOTC
IVSBF
Investor AB (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés